LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Medtronic Spine Launches Spine Essentials
Spine

Medtronic Spine Launches Spine Essentials

June 3, 2016 2 min read Premium comments

Advertisement

Medtronic Spine Launches Spine Essentials
Courtesy of Andrew Huth and RRY Publications, LLC ©
Secondary

Medtronic plc wants to differentiate itself by making 1- and 2-level cervical spinal fusions less expensive for hospitals.

To reach that goal, the company is launching Spine Essentials, a new platform of spinal implants and instruments, which the company says will make cervical spine fusion procedures “more efficient and help hospital systems manage costs, while maintaining quality.”

According to a May 19, 2016 announcement, the platform will accomplish this by “providing the exact tools in the right quantities needed to perform the cervical fusions, while reducing the costs and time required for instrument sterilization, case set up and inventory management.” The initiative fits right in line with the company’s surgical synergies strategic efforts.

“As a surgeon who routinely performs these types of surgeries, it’s helpful to optimize the implants and tools, so we’re being as efficient as possible to provide the best care possible to our patients, ” said Richard N.W. Wohns, M.D., orthopedic surgeon at neoSpine in Puyallup, Washington, and one of the physicians who collaborated with Medtronic to develop the platform.

Along with new product offerings such as Mazor’s robotics, surgical synergies will be the company’s “calling card, ” said company CEO Omar Ishrak during a conference call with analysts on May 31, 2016. “We’ve got very strong enabling technology platforms in navigation and imaging.”

Ishrak said Medtronic is differentiating spine procedures, both economically and clinically and the surgeon experience. “Just easier surgical procedures. This is going to take place quarter-over-quarter as we continue to emphasize this.”

“Things are looking very good for our Spine business right now, ” added Ishrak. “Every quarter we’ve improved over the last five quarters. And it’s a big shift, takes a little bit of time to change the direction and you should continue to see continued improvement quarter-over-quarter.

Spine Essentials implant sets include the most commonly used implant sizes for 1- and 2-level fusions of the neck (anterior cervical discectomy and fusions) and are sterile packaged with smaller instrument sets; thereby, says the company, reducing the amount of inventory a hospital needs to sterilize, set up and store. This platform will reduce sterilization costs associated with the procedure, including:

Advertisement

  • ~44% fewer instruments to sterilize compared with the full-sized configurations.
  • 91% fewer items to sterilize compared with the full-sized instrument and implant sets.
  • 67% reduction in number of cases to sterilize compared with the full-sized instrument and implant sets.

“Healthcare systems are under intense economic challenges, and Spine Essentials is an example of how Medtronic can bring value to spine surgery by optimizing costs and efficiency, ” said Doug King, senior vice president and president of Medtronic’s Spinal business.

The company said Spine Essentials incorporates technology developed by Gary K. Michelson, M.D.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy